HC
GILD icon

Hampstead Capital’s Gilead Sciences GILD Stock Holding History

Hampstead Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1.58M Hold
20,500
– – 2.83% 12
2018
Q2 		$1.45M Sell
20,500
-16,500
-45% -$1.17M 2.73% 13
2018
Q1 		$2.79M Sell
37,000
-3,000
-8% -$238K 3.75% 12
2017
Q4 		$2.87M Sell
40,000
-21,000
-34% -$1.59M 3.58% 12
2017
Q3 		$4.94M Hold
61,000
– – 4.9% 2
2017
Q2 		$4.32M Buy
61,000
+10,000
+20% +$665K 4.25% 5
2017
Q1 		$3.46M Buy
51,000
+10,000
+24% +$703K 3.58% 11
2016
Q4 		$2.94M Buy
+41,000
New +$3.05M 3.12% 21

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hampstead Capital's GILD Position: Q3 2018 in Review

Hampstead Capital held its Gilead Sciences (GILD) position steady in Q3 2018 at 20,500 shares worth $1.58M. The position accounts for 2.83% of the portfolio, ranked #12.

Hampstead Capital first reported a position in GILD in Q4 2016 and has held it in 8 quarters since. The position peaked at $4.94M in Q3 2017. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Hampstead Capital held 20,500 shares of Gilead Sciences worth $1.58M as of Q3 2018.
  • Hampstead Capital left its Gilead Sciences share count unchanged in Q3 2018.
  • Gilead Sciences made up 2.83% of Hampstead Capital's portfolio in Q3 2018, its #12 holding.
  • Hampstead Capital first reported a position in Gilead Sciences in Q4 2016 and has held it in 8 quarters since.
  • Hampstead Capital's Gilead Sciences position peaked at $4.94M in Q3 2017.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Hampstead Capital's 13F filing for Q3 2018, filed 14 Nov 2018.